Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Innate Pharma SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

INNATE PHARMA MARSEILLE (IPHYF=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

25 Jun 2016 Pechala's Reports 2 $25.00

Innate Pharma S.A. (IPH) - Financial Analysis Review

Innate Pharma S.A. (IPH) - Financial Analysis Review Summary Innate Pharma S.A. (Innate Pharma) is a bio-pharmaceutical compa...

17 Jun 2016 GlobalData 46 $300.00

Wright Investors Service Comprehensive Report for Innate Pharma S.A.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Jun 2016 Wright Reports 61 $75.00

Innate Pharma SA: Upgraded to Good

02 Jun 2016 Sadif Analytics Prime 3 $10.00

Is Now the Time to Buy Innate Pharma SA?

16 May 2016 Sadif Analytics Prime 12 $25.00

Company Snapshot - Innate Pharma

A director at Innate Pharma bought 2,000 shares at 12.170EUR and the significance rating of the trade was 52/100. Is that in...

05 Apr 2016 Directors Deals Ltd. 1 $12.00

Innate Pharma S.A. (IPH) - Financial Analysis Review

Innate Pharma S.A. (IPH) - Financial Analysis Review Summary Innate Pharma S.A. (Innate Pharma) is a bio-pharmaceutical compa...

17 Mar 2016 GlobalData 49 $300.00

Innate Pharma SA: Upgraded to Above Average

02 Mar 2016 Sadif Analytics Prime 3 $10.00

Is Innate Pharma SA Worth a Higher Bid?

15 Feb 2016 Sadif Analytics Prime 11 $25.00